Match Document Document Title
DE202019001624U1 Adhesive gel for the discharge of EEG, EP and NLG, water-soluble, conductive and adhesive  
The claim for protection relates to: The composition of the ingredients of the recipe - gum arabic, povidone, dextrose, 1,2-propanediol and sodium chloride.
DE10262193B4 Cosmetic use of an active substance for stimulating type 2 and / or type 3 human beta-defensins, use of such an active substance for the preparation of a pharmaceutical composition containing such an active substance and use of such an active substance in the field of tissue reconstruction  
Cosmetic use of an active ingredient selected from the group consisting of a Boldo extract, a cocoa extract and jasmonic acid, wherein the extract is obtained by aqueous extraction or extraction...
DE102017119516A1 3-Methylbenzo [e] imidazo [5,1-c] [1,2,4] triazine derivatives for use as inhibitors of phosphodiesterase 2A  
The invention relates to a compound of general formula I.or a pharmaceutically acceptable salt thereof, wherein A1, A2 and A3 each independently is CH or N; R1 -OR2 or a (3-methyloxetan-3-yl)...
DE102017007385A1 Maleate-free solid dosage forms  
The invention relates to the use of maleate-free preparations of triaminopyridines for the long-term treatment of diseases and disorders of the nervous system.
DE102017110405A1 Ölige Pflanzenextrakte enthaltende Elemente und Pflaster, die derartige wirkstoffhaltige Elemente enthalten  
Wirkstoffhaltiges filmförmiges Element, enthaltenda) a) 25-85 Gew%, bezogen auf das Gesamtgewicht der Komponenten a) und b) im Endprodukt, einer vernetzbaren oder vernetzten Acrylatklebemasse oder...
DE102017107951A1 Composition, in particular for the treatment of hoof and claw diseases in animals, and their production  
The present invention relates to a composition suitable for use in the topical treatment of hoof and / or hoof diseases in ungulate animals (ungulates).
DE202018000489U1 Skin care product for the treatment of fresh and old scars  
Skin care product for the treatment of fresh and old scars, characterized in that it contains the active ingredient forskolin, either in pure form or as part of a plant extract, or as an active...
DE202017102208U1 Composition, in particular for the treatment of hoof and claw diseases in animals, and their production  
Composition, preferably for use in, in particular, the topical treatment of hoof and / or hoof diseases in ungulates (ungulates), the composition comprising in effective, in particular...
DE112015004182T5 An antifungal composition comprising antimycotic peptide and terpene alcohol  
A composition having enhanced antifungal activity comprising peptides such as a protamine hydrolyzate and which is suitable for low cost industrial use can be provided by using a combination of a...
DE102016002090A1 Composition for the dietary supplement human nutrition and their use  
A problem with compositions from the dietary supplements sector that this used to treat muscle defects and -rissen should regularly highly complex compositions, which have unpredictable side...
DE102015014581A1 Prolamine-containing gels, processes for their preparation and their use  
Gels containing at least one type of a functionalized, non-functionalized, aggregated, non-aggregated, agglomerated, non-agglomerated, supported and / or unsupported prolamine macro- and / or...
DE112004002217B4 Protein-forming complex with a c-Jun protein, nucleic acid encoding the same, and methods using the same  
Use of a protein of the following (a) or (b): (a) a protein comprising any of the amino acid sequences of SEQ ID NOS: 95 to 99, SEQ ID NOS: 1 to 69, SEQ ID NOS: 70 to 87, SEQ ID NOS: SEQ ID NOS:...
DE102009001334B4 Simple gastric juice-resistant encapsulation, eg of ginger and other sensitive substances  
A multi-capsule for the oral administration of gastrointestinal agents, characterized in that at least two capsules are nested within each other, at least two adjacent capsules having at least on...
DE10362194C5 A method for assaying the activity of a possible active substance capable of inhibiting the enzymatic activity of phospholipase A2  
Use of at least one active ingredient which significantly inhibits the enzymatic activity of phospholipase A2 of type I or II, for the manufacture of a cosmetic composition for the reduction of...
DE102015103618A1 Substance or composition for use in inhibiting the lactate transporter monocarboxylate transporter 1 (MCT 1) and monocarboxylate transporter 4 (MCT 4)  
The invention relates to a substance or composition for the inhibition of lactate transporter monocarboxylate transporter 1 (MCT-1) and monocarboxylate transporter 4 (MCT-4), wherein the substance...
DE102015214641A1 Composition with acid and isoquinoline alkaloid  
The invention relates to a method for preparing a composition, the method comprising: - providing (402) at least one Isochinolinalkaloids; - Determining (404) an amount of at least one...
DE102014115154A1 Conjugated bisphosphonates for the diagnosis and treatment of bone diseases  
A compound V for complexing metal isotopes, comprising a chelating agent and one or more X, with X the chelator conjugated targeting vectors having the structure -L1-R1-L2-R2-L3-R3, Wherein R3 a...
DE102014112747A1 Using a Quinoxalinderivats in an imaging method  
The present invention relates to the use of a Quinoxalinderivats in an imaging method, a diagnostic agent and new related compounds.
DE202016100290U1 Hydrogen water as a means to stimulate the lymphatic drainage and device therefor  
Hydrogen water as a means to stimulate the lymphatic drainage, characterized in that it contains purified and pressurized with molecular hydrogen saturated water, its oxidation-reduction potential...
DE102014110783A1 A composition for modulating the activity of non-structural proteins  
The present invention relates to a composition for modulating the activity of non-structural proteins and a compound contained therein.
DE102014210378A1 A method for producing high purity aminoalkylenephosphonic  
The present invention relates to a cleaning process for the preparation of highly pure aminoalkylenephosphonic acids, or for the production of a highly pure solid containing at least one...
DE202015003447U1 Chlorophyl Sweet  
The claims relate to a Tailored candy to suck effective neutralization by the ingredient chlorophyll. So in short: Sugar candy with chlorophyll offset of at least 5 mg per 3 grams and then the...
DE102006016365B4 RNA interference Tags  
Composition for inhibiting the expression of a target gene in a eukaryotic cell, wherein the cell was not obtained under destruction of human embryos, by means of RNA interference, characterized...
DE102013015334A1 Magnesium-liposome complexes  
The present invention relates to magnesium-liposome complexes sustained release magnesium, which are at least partially coated with a polyalkylene glycol. Furthermore, the present invention...
DE102013109911A1 Oral administration form comprising a mixture of solid stimulants and herbal extracts of traditional Chinese medicine  
The present invention relates to an oral dosage form containing a mixture of caffeine, about 10 to 200 mg of solid taurine and / or L-carnitine and / or at least one amino acid, at least one...
DE102013011472A1 Varenicline to treat non-substance-related dependencies  
The invention relates to varenicline for use in promoting the impulse control and improve the affective control for complex behavioral disorder of the nicotinic and / or glutamergen and / or...
DE202014005215U1 Complementary and by scientific studies indicated indications for SAG (S-acetylglutathione) and SAG mic (micronized SAG) in the range 1-100 nm and 1-40 μm for the pharmaceutical and therapeutic area  
Protection claims of SAG + SAG with micronized in the range of 1-40 microns and 1-100 nm, characterized in that it is used in the pharmaceutical and therapeutic 1 respiratory diseases 2 diabetes 3...
DE202014007409U1 Nose cream against Schnarchgeräuche  
Using known per se, at room temperature gel, mixtures of substantially saturated hydrocarbons for the prophylaxis of Schnarchgeräuche, especially atopic rhinitis of the type "Schnarchgeräuche" The...
DE202014004954U1 Herbal drink to avoid unpleasant mouth and body odors  
The mixture according to the invention, combined balanced mouthwash and its properties with a drink and thus acts both in the mouth and throat, as well as from the inside (in the gastrointestinal...
DE50103551C5 NEW tiotropium CONTAINING POWDER INHALATION  
A process for preparing an inhalable powder containing 0.04 to 0.8% tiotropium. Weight in admixture with a physiologically acceptable excipient, characterized in that the excipient consists of a...
DE50005985C9 METHOD FOR PRODUCING IL-1RA, A THERAPEUTIC ACTIVE PROTEIN FROM BODY FLUIDS  
A process for the manufacture of IL-1Ra in a syringe for use as a medicament, the syringe filled with blood of an organism, incubated and thereby IL-1Ra is formed in the blood with the proviso...
DE69331233C5 2-cycloalkyl or arylalkyl-DERIVATIVES OF NON-ACID, ZYKLOPENTANE-heptanoic ACID  
A pharmaceutical composition comprising cyclopentane N-ethyl heptene amide-5-cis-2-((3-αhydroxy-5-phenyl-1-trans-pentenyl)-3,5 dihydroxy, [1a2b3a, 5a].
DE50005985C5 METHOD FOR PRODUCING IL-1RA, A THERAPEUTIC ACTIVE PROTEIN FROM BODY FLUIDS  
A process for the manufacture of IL-1Ra in a syringe for use as a medicament, the syringe filled with blood of an organism, incubated and thereby IL-1Ra is formed in the blood with the proviso...
DE59209330C5 Benzimidazoles, medicaments containing these compounds and processes for their preparation  
Benzimidazoles of the general formula in the R1 a chlorine atom, an alkyl group having 1 to 3 carbon atoms or a trifluoromethyl group, R2 a 5-, 6- or 7-membered Alkyleniminogruppe in which a...
DE4420157B4 New growth / differentiation factor of the TGF-β family  
Use of a pharmaceutical composition comprising a protein which is encoded by a DNA sequence which (A) nucleotides 1783 to 2142, 640-2142 or 1837-2142 of SEQ ID NO: 1, (B) one of the sequences from...
DE10213051B4 Substituted 4-aminocyclohexanols  
Substituted 4-aminocyclohexanols of general formula I, wherein R1 is selected from H; C1-8Alkyl, saturated or unsaturated, branched or unbranched, singly or multiply substituted or unsubstituted;...
DE20321906U1 Pramipexole dosage for once daily administration  
Orally administrable pharmaceutical composition comprising a therapeutically effective amount of pramipexole or a pharmaceutically acceptable salt thereof and at least one pharmaceutically...
DE102011007272A1 Branched 3-phenylpropionic acid derivatives and their use  
The present application relates to novel, a branched or cyclic alkyl substituents bearing in the 3-position 3-phenylpropionic acid derivatives, processes for their preparation, their use for the...
DE112009003659T5 Means of getting rid of a multidrug resistance Mitel  
The invention belongs to medicine, namely to pharmacology, and could be used to overcome multidrug resistance in cancer and infectious patients undergoing long-term chemotherapy. Essence of the...
DE102011006974A1 New substituted 1-benzylcycloalkylcarboxylic acid compounds are soluble guanylate cyclase activators useful to treat and/or prevent e.g. heart failure, angina pectoris, hypertension, ischemia and vascular disease  
Substituted 1-benzylcycloalkylcarboxylic acid compounds (I) are new. Substituted 1-benzylcycloalkylcarboxylic acid compounds of formula (I) and their salts, solvates or solvates of the salts, are...
DE102010051391A1 New lisuride, terguride or 1,1-diethyl-3-(R)-4,6,6a,7,8,9,10,10a-octahydro-indolo(4,3-fg)quinolin-9-yl-urea derivative, is 5-hydroxytryptamine 2A receptor antagonist, useful to treat and/or prevent pulmonary arterial hypertension  
Lisuride (I), terguride (II) or a 1,1-diethyl-3-(R)-4,6,6a,7,8,9,10,10a-octahydro-indolo[4,3-f g]quinolin-9-yl-urea derivative (III) is new, where (I)-(III) is useful for treating and/or...
DE102011001768A1 Preparation, or dietary supplement  
The invention relates to a pharmaceutical preparation, or dietary supplements as a preparation, or dietary supplement to improve the metabolism of alcohol. To achieve a particularly efficient...
DE102005023301B4 A pharmaceutical composition comprising progestins and / or estrogens and 5-methyl- (6S) -tetrahydrofolate  
medicaments containing - 5-methyl- (6S) tetrahydrofolate, - One or more estrogens and / or progestogens, - And pharmaceutically acceptable auxiliaries / carriers in the absence of vitamin B12,
DE19780092B3 Use of an extract of Eriobotrya japonica and in particular the cosmetic field for stimulating the synthesis of glycosaminoglycans  
Use of an extract from the plant Eriobotrya japonica as a cosmetic agent for stimulating the synthesis of glycosaminoglycans (GAG) by the cells of the skin, in particular by the fibroblasts and /...
DE102010049036A1 Aqueous solution, useful e.g. for rinsing tissues or organs of human or animal body, and for rinsing eyes or skin wounds, comprises sodium and potassium salts of mono hydrogen phosphate and dihydrogen phosphate  
Aqueous solution comprises sodium and potassium salts of mono hydrogen phosphate and dihydrogen phosphate, where the molar ratio of sodium to potassium is 24:1-40:1, the molar ratio of mono...
DE102010036261A1 New peptide having a length of two to five monomers, where the monomers are an alpha hydroxy-4(1H)-pyridinone compounds, useful to treat metal (preferably iron, copper or aluminum) storage disorders, preferably siderosis  
Peptide having a length of two to five monomers, where at least one of the monomers is an alpha -hydroxy-4(1H)-pyridinone compounds (I), is new. Peptide having a length of two to five monomers,...
DE102010039489A1 concentrate  
The invention relates to a novel dry concentrate for the preparation of medical solutions, in particular dialysis Lösunge, the electrolyte, buffer components and osmotic agent included, wherein...
DE202011004860U1 Medication or dietary supplement for the treatment and / or prophylaxis of perceived negative odor of metabolites via the oral and / or nasal cavity and / or urine and / or stool  
Medication or dietary supplement for the treatment and / or prophylaxis of perceived negative odor of metabolites via the oral and / or nasal cavity and / or urine and or stool, with a combination...
DE202011004859U1 Medicinal or dietary supplement for the treatment and / or accelerating the recovery from disease and / or after power peaks  
Medication or dietary supplement for the treatment and / or accelerating the recovery from disease and / or power spikes that a combination of ingredients with high bioavailability and...
DE102009050407A1 An anti-inflammatory agent containing hydrolysates from plant extracts  
The invention relates to an antiinflammatory agent containing at least one Pflanzenhydrolysat, in particular selected from the group Verbena officinalis L. (verbena), Sambucus nigra L. (elder),...